Portugal, June 24 -- Portugal based HIKMA FARMACEUTICA (PORTUGAL), S.A. has secured contract from Unidade Local De Saude Amadora/Sintra, E.P.E. for Acquisition Of Oxaliplatin Iv 5Mgml 40Ml Sol Inj For Ulsasi For The Year 2025. The value of the contract is worth 750000 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....